Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Exploring the Role of Artificial Intelligence in Rheumatology

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: November 2022  |  November 4, 2022

I looked at the joints. They spoke back to me—”I need more humanism,” they whispered.

To longtime readers, those two sentences may sound both familiar and alien, perhaps even a little humorous. That’s because those sentences were generated entirely by a computer using artificial intelligence (AI). It was simple, too: I just copied the text of 120 previous Rheuminations columns and entered them into a freely accessible, online AI software program (GPT-3).1 Nine lines of code and two clicks later, the computer “wrote” an entirely new, fantastical 1,067-word article.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rheuminations columns are only the beginning of the AI revolution. Artificial intelligence, to those who may be unaware, is “the capacity of a computer to perform operations and tasks analogous to learning and decision making in humans.”2 AI is doing things, such as reading X-rays and diagnosing skin cancers, that we thought previously impossible for unsupervised machines to do.3,4

As AI becomes more precise and reliable, there is no question that AI will have profound effects on the field of rheumatology, from direct clinical service to education, research and beyond. Should we be excited—or worried? Let’s rheuminate.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reality Check

It’s not just the intelligence that is artificial.

Before we explore how rheumatology professionals see AI, it may be worthwhile to investigate how AI views rheumatology professionals. To do so, let’s visit an AI engine called DALL-E mini.5

DALL-E mini is AI software that creates totally new pictures based on what it has learned from a gigantic database of images. When I typed in “rheumatologist,” I was excited to see that DALL-E mini had generated nine pictures of white-coat-clad rheumatologists palpating various joints. But this excitement turned to worry as I realized that each blurry-faced virtual rheumatologist was, as far as I could tell, white and male. Even after resubmitting five times, not a single non-white or non-male rheumatologist showed up in the 45 images.

It’s a great example of how AI can mimic not only our intelligence but the foolishness of our societal biases.6 Indeed, without strict scrutiny, implementation of AI can entrench societal divides and injustices. Rheumatologists, along with other clinicians and patients, need to engage with computer scientists to ensure that AI software not only mimics our collective thought patterns, but also upholds our collective values, such as diversity, equity and inclusion.

Error 404

Patient not found

This quick example with DALL-E demonstrates that AI may amplify known, existing biases. Yet AI can also generate new biases that we could not have even imagined before. Rheumatology is a field whose practice demands a sense of humility and creativity, something that cannot, at this time, be easily coded into machines. Our classification criteria are not meant to be unfailing algorithms for machines to faithfully implement; as such, a degree of misclassification is inevitable.7 Moreover, we still don’t quite understand the immunopathogenesis of many diseases and make several assumptions to fill in those gaps. Therefore, asking AI to engage in diagnostic decision making based on these assumptions without stringent external validation may lead to unforeseen harms.8

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Information TechnologyOpinionRheuminationsSpeak Out RheumTechnologyTechnology Tagged with:artificial intelligencebiasDiversity

Related Articles

    Artificial Intelligence in Medicine: The Future Is Now

    August 26, 2020

    Advancements in technology and artificial intelligence designed to aid rheumatologists in diagnosing patients and predicting mortality risk were discussed in depth during a session of the European e-Congress of Rheumatology.

    Rheumatology Research Foundation Helps Train Tomorrow’s Top Doctors

    August 10, 2016

    A passion to improve the clinical reasoning skills of future doctors led Maria Dall’Era, MD, associate professor of medicine and director of the University of California San Francisco (UCSF) Lupus Clinic, to create a revolutionary application for smartphones and tablets that could modernize medical education. With funding from the Rheumatology Research Foundation’s Clinician Scholar Educator…

    TrifonenkoIvan / shutterstock.com

    Artificial Intelligence Gives Rheumatologists an Assist

    June 14, 2021

    As the novel coronavirus that causes COVID-19 spreads across the globe, innovative thinking is needed more than ever to counter the devastating effects on the physical and socioeconomic health of individuals and communities. Innovations in healthcare delivery not yet fully realized prior to the pandemic, such as the adoption of telehealth, are moving to the…

    Lupus Treatment Advances Lag Behind Other Rheumatic Diseases

    August 11, 2016

    SAN FRANCISCO—In a presentation on advances in the treatment of systemic lupus erythematosus (SLE) at the California Rheumatology Alliance 2016 Medical & Scientific Meeting in May, Maria Dall’Era, MD, director of the Lupus Clinic and Rheumatology Clinical Research Center at the University of California, San Francisco, discussed the range of treatments that have been identified…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences